Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian Responders Undergoing ICSI
NCT05900661Phase 3Unknown
- Sponsor
- Beni Suef University
- Start
- Jul 2023
- Primary completion
- Sep 2023
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in infertility comparing myo-inositol, Somatropin and Dehydroepiandrosterone (3 arms). Primary endpoint: Number and maturity of oocytes retrieved at 1 month. Status: unknown.
02
Drugs
myo-inositolsomatropindehydroepiandrosterone
03
Conditions
infertility
Beyond the preview
Go deeper on NCT05900661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05900661.